Eli Lilly & Co. (ticker: LLY) has quietly become a titan of Wall Street. Fuelled by two blockbuster Glucagon-like peptide-1 (GLP‑1) drugs (Mounjaro for diabetes …
Sign up for our free newsletter and receive the latest banking and fintech stories, straight to your inbox - every week
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
